Targeting Stress-Driven Inflammatory and Angiogenic Pathways With Brief ACT to Enhance Neoadjuvant Chemotherapy Response in Locally Advanced Breast Cancer

NCT07570368 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Breast Neoplasm Female
Locally Advanced Breast Cancer (LABC)
Locally Advanced Breast Cancer

Interventions

BEHAVIORAL: Brief Acceptance and Commitment Therapy
BEHAVIORAL: Standard Counseling
DRUG: Neoadjuvant Chemotherapy

Sponsor

Universitas Airlangga